ArticleExperimental and therapeutic medicine2026
Unveiling the comorbidity hub: WT1 drives renal cancer progression in chronic kidney disease and confers sirolimus vulnerability.
Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.